End Stage Renal Disease. End-stage renal disease
Conditions
Interventions
Sponsors
Vice Chancellor for Research, Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patient’s satisfaction, hemodialysis for at least 1 month prior to the study, hemoglobin concentration less than 10g/dL in at least 2 episodes, Erythropoietin use more than 12000 units per week, no bleeding over the last month prior to the intervention, no infection resulting admission over the last month prior to the intervention, vitamin C consumption 250mg twice a week Exclusion criteria: drug intolerance, bleeding during the study period, infection resulting admission
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum hemoglobin level. Timepoint: Baseline, monthly, at the end of the study. Method of measurement: g/dL.;Serum albumin. Timepoint: Baseline, monthly, at the end of the study. Method of measurement: g/dL.;Erythropoietin use. Timepoint: monthly. Method of measurement: International unit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum Iron level. Timepoint: Baseline, 3rd month, at the end of study. Method of measurement: µg/dL.;Total iron binding capacity. Timepoint: Baseline, 3rd month, at the end of study. Method of measurement: µg/dL. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mojgan Mortazavi
Isfahan University of Medical Science
Outcome results
None listed